Sign in
Explore the registryTrack Relatlimab's trials

RELATIVITY-047

A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma

RelatlimabOngoingActive not recruitingPhase 2Open NCT03470922 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…